Rnr inhibitor COH29
N-[4-(3,4-dihydroxyphenyl)-5-phenyl-1,3-thiazol-2-yl]-3,4-dihydroxybenzamide
Molecular Identity
Rnr inhibitor COH29
N-[4-(3,4-dihydroxyphenyl)-5-phenyl-1,3-thiazol-2-yl]-3,4-dihydroxybenzamide
PubChem CID: 44253415
2D Structure
Properties
C22H16N2O5S
Molecular Formula
420.40
Molecular Weight
g/mol
420.0780
Exact Mass
Da
4
XLogP
Drug-like (Lipinski: < 5)
151
TPSA
May have limited oral absorption
5
H-Bond Donors
7
H-Bond Acceptors
590
Complexity
SMILES
Canonical SMILES
SMILES: C1=CC=C(C=C1)C2=C(N=C(S2)NC(=O)C3=CC(=C(C=C3)O)O)C4=CC(=C(C=C4)O)OIsomeric SMILES
SMILES: C1=CC=C(C=C1)C2=C(N=C(S2)NC(=O)C3=CC(=C(C=C3)O)O)C4=CC(=C(C=C4)O)OSynonyms(20)
Rnr inhibitor COH29N-(4-(3,4-dihydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihydroxybenzamideCOH29 compoundRefChem:127411Ribonucleotide Reductase Holoenzyme Inhibitor COH29COH291190932-38-7COH-29N-[4-(3,4-dihydroxyphenyl)-5-phenyl-1,3-thiazol-2-yl]-3,4-dihydroxybenzamide07802BU06SBenzamide, N-(4-(3,4-dihydroxyphenyl)-5-phenyl-2-thiazolyl)-3,4-dihydroxy-Benzamide, N-[4-(3,4-dihydroxyphenyl)-5-phenyl-2-thiazolyl]-3,4-dihydroxy-MFCD28502212COH 29orb1226845
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Rnr inhibitor COH29
Loading drug network...